Matthew Maxwell Donley Aurinia Pharmaceuticals Inc. (AUPH) insider trading activity

Matthew Maxwell Donley is EVP, Ops & Strategy of Aurinia Pharmaceuticals Inc.. Currently has a direct ownership of 584,072 shares of AUPH, which is worth approximately $5.17 Million. The most recent transaction as insider was on Mar 06, 2024, when has been sold 40,665 shares (Common Stock) at a price of $5.51 per share, resulting in proceeds of $224,064. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 584K

0% 3M change

44.88% 12M change

Total Value Held $5.17 Million

Matthew Maxwell Donley Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 06 2024	SELL Open market or private sale	$224,064 $5.51 p/Share	40,665 Reduced 6.51%	584,072 Common Stock
Feb 20 2024	BUY Grant, award, or other acquisition	-	216,666 Added 25.75%	624,737 Common Stock
Mar 02 2023	BUY Grant, award, or other acquisition	-	271,134 Added 40.21%	403,141 Common Stock
Nov 21 2022	BUY Open market or private purchase	$46,600 $4.66 p/Share	10,000 Added 26.37%	27,927 Common Stock
Mar 02 2022	SELL Open market or private sale	$36,655 $12.01 p/Share	3,052 Reduced 15.83%	16,224 Common Stock
Mar 02 2022	BUY Grant, award, or other acquisition	-	8,500 Added 30.6%	19,276 Common Stock
May 11 2021	BUY Open market or private purchase	$99,693 $10.07 p/Share	9,900 Added 50.0%	9,900 Common Stock

MMD

Matthew Maxwell Donley

EVP, Ops & Strategy

Victoria, A1

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AUPH shares.

Notify only if

Value

Insider Trading

Get notified when an Aurinia Pharmaceuticals Inc. insider buys or sells AUPH shares.

Notify only if

Operation

Value

Type

News

Receive news related to Aurinia Pharmaceuticals Inc.

Track Activities on AUPH

Account